Borgestad ASA (LON:0DTO)

Oncternal Therapeutics Revenue

Borgestad ASA had revenue of 206.46M NOK in the quarter ending March 31, 2025, a decrease of -7.32%. This brings the company's revenue in the last twelve months to 1.12B, up 1.22% year-over-year. In the year 2024, Borgestad ASA had annual revenue of 1.14B with 3.08% growth.

• Revenue (ttm): 1.12B NOK
• Revenue Growth: +1.22%
• P/S Ratio: 0.64
• Revenue / Employee: 1.74M NOK
• Employees: 645
• Market Cap: 52.71M USD

Revenue Chart

* This company reports financials in NOK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.14B	34.06M	3.08%
Dec 31, 2023	1.11B	187.42M	20.40%
Dec 31, 2022	918.77M	35.52M	4.02%
Dec 31, 2021	883.26M	44.32M	5.28%
Dec 31, 2020	838.94M	-50.09M	-5.63%